Literature DB >> 18242618

Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.

Qi Chen1, Hamid Razzaghi, F Yesim Demirci, M Ilyas Kamboh.   

Abstract

Lipoprotein lipase (LPL) plays a pivotal role in lipid metabolism by hydrolyzing triglyceride (TG)-rich lipoprotein particles. Abnormalities in normal LPL function are associated with the risk of coronary artery disease (CAD). A number of genetic variants have been identified in the LPL gene that affects different functions of the LPL protein. A common HindIII polymorphism in intron 8 (T/G) of the LPL gene has been found to be associated with altered plasma TG and HDL-cholesterol, and CAD risk in several studies, but its functional significance is unknown. It has been shown that certain intronic sequence contain regulatory elements that are important for transcription and translational regulation of a gene. In this study we tested the hypothesis that this polymorphism affects the binding site of a transcription factor that regulates the transcription of LPL gene. Electrophoretic mobility shift assays (EMSAs) revealed that the HindIII site binds to a transcription factor and that the mutant allele has lower binding affinity than the wild type allele. Transcription assays containing the entire intron 8 sequence along with full-length human LPL promoter were carried out in COS-1 and human vascular smooth muscle cells. The mutant allele was associated with significantly decreased luciferase expression level compared to the wild type allele in both the muscle (3.394+/-0.022 vs. 4.184+/-0.028; P=4.7 x 10(-6)) and COS-1 (11.603+/-0.409 vs. 14.373+/-1.096; P<0.0001) cells. In conclusion, this study demonstrates for the first time that the polymorphic HindIII site in the LPL gene is functional because it affects the binding of a transcription factor and it also has an impact on LPL expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242618      PMCID: PMC2603421          DOI: 10.1016/j.atherosclerosis.2007.12.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  44 in total

1.  The translational regulation of lipoprotein lipase in diabetic rats involves the 3'-untranslated region of the lipoprotein lipase mRNA.

Authors:  G Ranganathan; C Li; P A Kern
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

2.  Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study.

Authors:  C Garenc; L Pérusse; J Gagnon; Y C Chagnon; J Bergeron; J P Després; M A Province; A S Leon; J S Skinner; J H Wilmore; D C Rao; C Bouchard
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

3.  Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance.

Authors:  Melchior C Nierman; Jaap Rip; Jan-Albert Kuivenhoven; Daniel H van Raalte; Barbara A Hutten; Naohiko Sakai; John J P Kastelein; Erik S G Stroes
Journal:  Metabolism       Date:  2005-11       Impact factor: 8.694

Review 4.  Lipoprotein lipase, a key role in atherosclerosis?

Authors:  J R Mead; A Cryer; D P Ramji
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

Review 5.  Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation.

Authors:  Jaap Rip; Melchior C Nierman; Colin J Ross; Jan Wouter Jukema; Michael R Hayden; John J P Kastelein; Erik S G Stroes; Jan Albert Kuivenhoven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-30       Impact factor: 8.311

Review 6.  Functional variants in the lipoprotein lipase gene and risk cardiovascular disease.

Authors:  J E Hokanson
Journal:  Curr Opin Lipidol       Date:  1999-10       Impact factor: 4.776

7.  Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease.

Authors:  E K Luedecking; S T DeKosky; H Mehdi; M Ganguli; M I Kamboh
Journal:  Hum Genet       Date:  2000-05       Impact factor: 4.132

8.  Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels.

Authors:  H Razzaghi; C E Aston; R F Hamman; M I Kamboh
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

9.  In vitro assays fail to predict in vivo effects of regulatory polymorphisms.

Authors:  Elizabeth T Cirulli; David B Goldstein
Journal:  Hum Mol Genet       Date:  2007-06-12       Impact factor: 6.150

10.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.

Authors:  R E Peacock; A Hamsten; P Nilsson-Ehle; S E Humphries
Journal:  Atherosclerosis       Date:  1992-12       Impact factor: 5.162

View more
  16 in total

1.  Lipoprotein lipase variants interact with polyunsaturated fatty acids for obesity traits in women: replication in two populations.

Authors:  Y Ma; K L Tucker; C E Smith; Y C Lee; T Huang; K Richardson; L D Parnell; C Q Lai; K L Young; A E Justice; Y Shao; K E North; J M Ordovás
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-07-22       Impact factor: 4.222

2.  Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population.

Authors:  Parthasaradhi Reddy Tanguturi; Bhoomireddy Pullareddy; B S Rama Krishna; Dwarkanath K Murthy
Journal:  Indian Heart J       Date:  2013-11-13

3.  Lipoprotein lipase gene sequencing and plasma lipid profile.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2013-11-09       Impact factor: 5.922

4.  Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.

Authors:  María-José Ariza; Miguel-Angel Sánchez-Chaparro; Francisco-Javier Barón; Ana-María Hornos; Eva Calvo-Bonacho; José Rioja; Pedro Valdivielso; José-Antonio Gelpi; Pedro González-Santos
Journal:  BMC Med Genet       Date:  2010-04-29       Impact factor: 2.103

5.  Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar.

Authors:  Andrew J P Smith; Jutta Palmen; Wendy Putt; Philippa J Talmud; Steve E Humphries; Fotios Drenos
Journal:  Hum Mol Genet       Date:  2010-07-22       Impact factor: 6.150

6.  Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease.

Authors:  Mohamed S Daoud; Farid S Ataya; Dalia Fouad; Amal Alhazzani; Afaf I Shehata; Abdulaziz A Al-Jafari
Journal:  Biomed Rep       Date:  2013-05-30

7.  Resequencing of LPL in African Blacks and associations with lipoprotein-lipid levels.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; Clareann H Bunker; M Michael Barmada; M Ilyas Kamboh; F Yesim Demirci
Journal:  Eur J Hum Genet       Date:  2015-01-28       Impact factor: 4.246

8.  Elite athletes' genetic predisposition for altered risk of complex metabolic traits.

Authors:  Lauren K Banting; Vladimir P Pushkarev; Pawel Cieszczyk; Aleksandra Zarebska; Agnieszka Maciejewska-Karlowska; M-Arek Sawczuk; Agata Leońska-Duniec; Dmitry A Dyatlov; Evgeniy F Orekhov; Aleksandr V Degtyarev; Yuliya E Pushkareva; Xu Yan; Ruth Birk; Nir Eynon
Journal:  BMC Genomics       Date:  2015-01-23       Impact factor: 3.969

Review 9.  Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.

Authors:  Li Xie; You-Mei Li
Journal:  Int J Environ Res Public Health       Date:  2017-01-16       Impact factor: 3.390

10.  Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways.

Authors:  David A Ewald; Dana Malajian; James G Krueger; Christopher T Workman; Tianjiao Wang; Suyan Tian; Thomas Litman; Emma Guttman-Yassky; Mayte Suárez-Fariñas
Journal:  BMC Med Genomics       Date:  2015-10-12       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.